Approximately 12% of all cancer cases worldwide in 2024—amounting to 2.3 million new diagnoses—were directly linked to infections, according to a comprehensive study published in The Independent by researchers from the World Health Organization and The Lancet Oncology. The findings underscore that millions of malignancies globally stem from preventable or treatable pathogens, reigniting public health debates over vaccine distribution and screening equity.
The research evaluated the frequency and underlying causes of diverse malignancies, revealing that the vast majority of infection-driven cancers trace back to just five major pathogens: Helicobacter pylori at 4%, human papillomavirus (HPV) at 4%, hepatitis B at 2%, Epstein-Barr virus at 1%, and hepatitis C at under 1%. These biological agents collectively drive more than 20 distinct cancer types, including malignancies affecting the stomach, liver, blood, and cervix.
Former WHO Chief Scientist Dr. Soumya Swaminathan emphasized the gravity of these findings on social media, writing that pathogens like HPV, H. pylori, and hepatitis viruses drive over 2 million cancers globally every year, pointing to an urgent need for policy shifts.
Biological Mechanisms and Regional Disparities
Understanding how pathogens induce oncogenesis involves distinct biological pathways. Viruses can directly or indirectly alter host cell genetics, driving uncontrolled cell division. Mechanisms include inactivating tumor-suppressor proteins such as TP53 and RB, integrating viral DNA into host genomes to disrupt cell-cycle regulation, or carrying specific oncogenes acquired from other organisms.
Conversely, bacteria and parasites induce malignancy more indirectly through chronic tissue stress and inflammation. Persistent immune activation damages cellular structures and forces rapid cellular turnover, which increases the likelihood of copying errors and genetic mutations. For instance, chronic Helicobacter pylori infections cause prolonged inflammation of the gastric mucosa, escalating gastric cancer risks if left untreated.
Geographic equity remains a central challenge in tackling these figures. The Independent reported that approximately 75% of infection-linked cancers occur in low- and middle-income countries, where access to vaccination programs, antiviral therapies, and early screening remains constrained.
Public Health Implications and Prevention Efforts
While lifestyle factors and genetic predispositions frequently dominate public health discourse, regional data demonstrates how infection pathways translate into heavy clinical burdens. In India, nearly 1.9 million cancer cases in 2024 were linked to infections, with regional registries indicating thousands of potential cases tied to H. pylori and viral pathogens in areas like Telangana, according to Telangana Today.
Public health experts stress that expanding vaccination coverage and antiviral therapies can interrupt these disease progressions. However, maintaining high immunization thresholds remains critical. In Australia, where school-based human papillomavirus vaccination programs drastically reduced HPV infections by 90% since 2007, health authorities have noted a concerning drop in 15-year-old vaccination rates from 85.7% in 2020 to 79.5% in 2024, falling short of the WHO target to immunize 90% of eligible adolescents by 2030.